Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Forman

Showing results (561-570 of 657) with videos related to

Pageof 66
Sort By:
The British Journal of Surgery|January 5, 2013
Population-based study of laparoscopic colorectal cancer surgery 2006-2008E F Taylor, J D Thomas, L E Whitehouse, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 4, 2015
Childhood cancer incidence in South Africa, 1987-2007D C Stefan, D K Stones, R D Wainwright, et al.
Human Gene Therapy|March 12, 2005
Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii proteinYu Wang, Minzhen Xu, Mingxin Che, et al.
British Journal of Cancer|February 9, 2013
Management of colorectal cancer explains differences in 1-year relative survival between France and England for patients diagnosed 1997-2004O Dejardin, B Rachet, E Morris, et al.
British Journal of Haematology|June 26, 2003
Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantationRaymond Wong, Guillermo Z Beguelin, Marcos de Lima, et al.
Nutrition and Cancer|October 7, 2010
Soy isoflavones in conjunction with radiation therapy in patients with prostate cancerIftekhar U Ahmad, Jeffrey D Forman, Fazlul H Sarkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809R I Fisher, B W Dana, M LeBlanc, et al.
The Journal of Physical Chemistry. B|August 18, 2023
Delineating Structural Propensities of the 4E-BP2 Protein via Integrative Modeling and ClusteringThomas E Tsangaris, Spencer Smyth, Gregory-Neal W Gomes, et al.
Nutrition and Cancer|October 12, 2007
Lycopene and soy isoflavones in the treatment of prostate cancerUlka Vaishampayan, Maha Hussain, Mousumi Banerjee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 13, 2016
Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancerJeffrey V Brower, Jeffrey D Forman, Patrick A Kupelian, et al.
Pageof 66

Showing results (561-570 of 657) with videos related to

Sort By:
Pageof 66
The British Journal of Surgery|January 5, 2013
Population-based study of laparoscopic colorectal cancer surgery 2006-2008E F Taylor, J D Thomas, L E Whitehouse, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 4, 2015
Childhood cancer incidence in South Africa, 1987-2007D C Stefan, D K Stones, R D Wainwright, et al.
Human Gene Therapy|March 12, 2005
Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii proteinYu Wang, Minzhen Xu, Mingxin Che, et al.
British Journal of Cancer|February 9, 2013
Management of colorectal cancer explains differences in 1-year relative survival between France and England for patients diagnosed 1997-2004O Dejardin, B Rachet, E Morris, et al.
British Journal of Haematology|June 26, 2003
Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantationRaymond Wong, Guillermo Z Beguelin, Marcos de Lima, et al.
Nutrition and Cancer|October 7, 2010
Soy isoflavones in conjunction with radiation therapy in patients with prostate cancerIftekhar U Ahmad, Jeffrey D Forman, Fazlul H Sarkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809R I Fisher, B W Dana, M LeBlanc, et al.
The Journal of Physical Chemistry. B|August 18, 2023
Delineating Structural Propensities of the 4E-BP2 Protein via Integrative Modeling and ClusteringThomas E Tsangaris, Spencer Smyth, Gregory-Neal W Gomes, et al.
Nutrition and Cancer|October 12, 2007
Lycopene and soy isoflavones in the treatment of prostate cancerUlka Vaishampayan, Maha Hussain, Mousumi Banerjee, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 13, 2016
Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancerJeffrey V Brower, Jeffrey D Forman, Patrick A Kupelian, et al.
Pageof 66